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Parasitic nematodes represent formidable pathogens of humans, livestock and crop plants. Control of
these parasites is almost exclusively dependent on a small group of anthelmintic drugs, the most impor-
tant of which belong to the macrocyclic lactone class. The extensive use of these drugs to control the
ubiquitous trichostrongylid parasites of grazing livestock has resulted in the emergence of both single
and multi-drug resistance. The expectation is that this resistance will eventually occur in the human par-
asites such as the common and debilitating soil transmitted nematodes and vector-borne filarial nema-
todes. While the modes of action of anthelmintics such as ivermectin, have been elucidated, notably in
the model nematode Caenorhabditis elegans, the molecular nature of this resistance remains to be fully
determined. Here we show that the anterior amphids play a key role in ivermectin uptake and mutations
in these sensory structures result in ivermectin resistance in C. elegans. Random genetic mutant screens,
detailed analysis of existing amphid mutants and lipophilic dye uptake indicate that the non-motile cil-
iated amphid neurons are a major route of ivermectin ingress; the majority of the mutants characterised
in this study are predicted to be involved in intraflagellar transport. In addition to a role in ivermectin
resistance, a subset of the amphid mutants are resistant to the non-related benzimidazole class of anthel-
mintics, raising the potential link to a multi-drug resistance mechanism. The amphid structures are pre-
sent in all nematodes and are clearly defined in a drug-sensitive strain of Haemonchus contortus. It is
predicted that amphidial drug uptake and intraflagellar transport may prove to be significant in the
development of single and multi-drug resistance in the nematode pathogens of veterinary and human
importance.
 2018 The Author(s). Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Nematodes represent important pathogens of humans and
farmed livestock that have a significant impact on human health
and the viability of livestock production. In both human and veteri-
nary medicine, limited control options are available and are heav-
ily dependent on the administration of a small group of broad-
spectrum anthelmintic classes of drugs (Geary, 2005) including
the macrocyclic lactones. The effectiveness of the macrocyclic lac-
tones such as ivermectin (IVM) in killing nematodes was discov-
ered during the 1970–80s (Campbell and Benz, 1984) and the
key role this drug class plays in the control of veterinary, and
human, parasitic nematode infections was recognised through
the award of the Nobel Prize for Physiology and Medicine in
2015 (https://www.nobelprize.org/prizes/medicine/2015/sum-
mary/). Resistance to the broad-spectrum anthelmintics such as
IVM, levamisole (LEV) and albendazole (ABZ) is now becomingcommonplace in veterinary medicine (Kotze and Prichard, 2016),
with real concerns that this situation may ultimately be echoed
in human infections (with soil transmitted nematodes, Onchocerca,
and filarial nematodes) that are currently being controlled through
mass drug administration programmes (Geerts and Gryseels,
2000). However, the precise molecular and biochemical mecha-
nisms, particularly in response to the widely used macrocyclic lac-
tone class, remain poorly understood and have been predicted to
be multifactorial (Kotze and Prichard, 2016) involving, for example,
ligand gated channels, GABA receptors and potentially tubulins.
There is also increasing evidence for the involvement of drug trans-
porters and detoxifying enzymes (Kotze and Prichard, 2016). Pre-
sently, there are no definitively confirmed IVM resistance genes
that have been identified in parasitic nematodes.
The mode of action of IVM was defined by genetic analysis in
the model nematode Caenorhabditis elegans and found to be via
glutamate-gated chloride ion channels, resulting in channel activa-
tion and flaccid paralysis (Cully et al., 1994). Genetic studies iden-
tified the main glutamate-gated receptor genes, glc-1, avr-14 and
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levels of resistance (Dent et al., 2000). A further six non-glutamate-
gated genes were identified in this original IVM resistance screen,
four of which (osm-1, osm-5, dyf-11 and che-3) are related to the
sensory neural amphid structures (Dent et al., 2000). The molecu-
lar elucidation of resistance mechanisms in field isolates of para-
sitic nematodes, even following the completion of the genome
sequence in species such as Haemonchus contortus (Laing et al.,
2013; Schwarz et al., 2013), has not, to date, directly linked specific
glutamate-gated receptors with IVM resistance.
The C. elegansmodel represents an excellent system in which to
examine the role of the amphids in drug uptake and in the gener-
ation of resistance. The amphids are a pair of anterior structures
comprising non-motile cilia terminating in dendritic process at
the nerve ring, are involved in sensing the physical and chemical
environment and are analogous in many respects to a vertebrate
nose. Defects in these sensilla structures in C. elegans are associated
with numerous phenotypes including abnormal chemotaxis (Che),
abnormal avoidance of high osmolarity (Osm), abnormal dauer for-
mation (Daf), and abnormal dye-filling (Dyf) (Starich et al., 1995).
The Dyf mutants are characterised by their inability to take up flu-
orescent dyes such as FITC and Dil, which in wild-type C. elegans
are taken up by the anterior amphid and posterior phasmid struc-
tures. Laser ablation of these amphidial cells does not affect post-
embryonic viability but instead leads to constitutive dauer forma-
tion (a long-lived larval stage) (Bargmann and Horvitz, 1991). A
previous extensive genetic characterisation of Dyf mutants in C.
elegans identified 95 new Dyf mutants representing 13 new dyf
genes but also included 12 new alleles of pre-existing genes, many
of which were chemotaxis defective (Starich et al., 1995).
In this present study, forward genetic screens were applied to
investigate the link between Dyf mutants and IVM resistance. To
support this link, the IVM resistance properties of a selection of
previously identified C. elegans amphid and chemosensory mutants
that were not known to be associated with anthelmintic resistance,
were examined and identified as novel IVM resistance genes. The
amphidial uptake of fluorescent dyes and the presence of the
IVM resistance gene homologues in the parasitic nematode H. con-
tortus were also examined.2. Materials and methods
All fine chemicals were purchased from Sigma (UK) unless
otherwise stated.Table 1
Caenorhabditis elegans macrocyclic lactone resistance mutants isolated in forward
mutagenic screens.
Mutant strain Resistance screen Dyf amphid ABZ R (100 mM)
TP236(ka30) IVM 10 nM screen 1 Dyf  No
TP237(ka31) ABM 50 nM screen 2 Dyf  No
TP238(ka32) IVM 10 nM screen 1 Dyf + No
TP239(ka33) IVM 10 nM screen 1 Dyf + No
TP240(ka34) ABM 50 nM screen 3 Dyf  No
TP241(ka35) ABM 50 nM screen 3 Dyf  Yes
TP242(ka36) ABM 50 nM screen 3 Dyf  No
TP243(ka37) ABM 50 nM screen 3 Dyf  No
TP249(ka43) ABM 50 nM screen 3 Dyf  No
TP250(ka44) IVM 10 nM screen 1 Dyf  No
TP271(ka63) IVM 10 nM screen 4 Dyf  No
TP272(ka64) IVM 10 nM screen 4 Dyf  No
TP273(ka65) IVM 10 nM screen 4 Dyf  No
TP274(ka66) IVM 10 nM screen 4 Dyf  No
TP275(ka67) IVM 10 nM screen 4 Dyf  No
TP173(ka98) IVM 10 nM screen 1 Dyf  No
TP153(ka99) IVM 10 nM screen 1 Dyf  No
Dyf, amphid dye-filling; IVM, ivermectin; ABM, abamectin; ABZ R, albendazole
resistant.2.1. Nematode strains and maintenance
Caenorhabditis elegans strains were supplied by the C. elegans
Genetics Centre, USA and were maintained on Nematode Growth
Media (NGM) agar plates supplemented with Escherichia coli bacte-
ria OP50-1 following standard techniques http://www.wormbook.
org/toc_wormmethods.html. The following strains were used in
this study; N2, CB3323 (che-13), CB3332 (che-12), SP1205 (dyf-1),
MT3559 (dyf-9), CB3687 (che-14), MX52 (bbs-8), SP1745 (dyf-5),
PR811 (osm-6), PR672 (che-1), SP1234 (dyf-2), PR813 (osm-5),
PR802 (osm-3), SP1237 (dyf-4), CB3330 (che-11), DR86 (daf-19),
CB1126 (che-6), SP1678 (dyf-13), SP1709 (dyf-10), SP1603 (dyf-3),
SP1735 (dyf-7), CB398 (mec-8), SP1712 (dyf-6), CB1033 (che-2),
CB1387 (daf-10), CB1066 (mec-1), SP1713 (dyf-11), VC837 (bbs-1),
CB3329 (che-10), MT3645 (osm-12), CB1124 (che-3), CB1253
(che-3), CB4856 (Hawaiian strain) and PR808 (osm-1).
The drug-sensitive H. contortus strain, MHco3(ISE), was kindly
provided by Dave Bartley and Alison Morrison from the Moredun
Research Institute, UK. Embryos were purified from faecal samples
derived from mono-specifically infected donor lambs via saturatedsalt flotation. The eggs were hatched to L1s and developed to L2s
and L3s by culturing on NGM agar OP50-1 as per C. elegans.
2.2. IVM, abamectin and ABZ resistance test in C. elegans
IVM and abamectin stocks were made up in solvent (DMSO final
volume 1%) and added to cooled (50 C) NGM media, at 8–50 nM
final concentrations prior to pouring 5 cm plates then seeding with
OP50-1 and plates were used the next day. For resistance assays
either 50 purified embryos, five L4s or five young adults were
placed on drug selection plates. Resistance was assessed as F1 sur-
vival after 3 to 5 days. All wild type (N2) and Hawaiian (CB4856)
nematodes were dead on 8–10 nM IVM after 5 days and failed to
progress beyond L1s, but all resistance mutants survived these
conditions, developing to adults. For ABZ, the same process was
followed, except 100 mM (or 150 mM) ABZ was added to the cooled
NGM plates, and drug effectiveness was determined as complete
paralysis of all N2 worms after 3–5 days whereas resistant worms
were active and moved freely on the ABZ plates.
2.3. EMS mutagenesis
Four separate chemical mutagenesis screens (Table 1) were
carried on wild type N2 C. elegans with ethyl methanesulfonate
(EMS) following previously published methods (Brenner, 1974).
Briefly, synchronised L4s were washed from plates in M9 buffer
and incubated in 50 mM EMS for 4 h at 20 C, washed in M9,
and allowed to recover on NGM plates overnight. Twenty adults
per plate were transferred to 60  9 cm Petri dishes for each
screen, overall representing a large mutagenic screen at approxi-
mately 400,000 mutagenised F1 genomes. Populations were then
allowed to develop to F2 adults which were bleached and result-
ing eggs were placed on 10 or 50 nM IVM or 50 nM ABZ selection
plates. Surviving nematodes from individual plates were main-
tained as separate mutants.
2.4. Mutant single nucleotide-polymorphism (SNP) mapping and
whole genome sequencing
Two IVM-resistant mutants, TP238(ka32) and TP239(ka33),
were selected for whole genome sequencing following backcross-
ing to a polymorphic SNP-rich Hawaiian C. elegans strain
(CB4856) essentially as described (Doitsidou et al., 2010).
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also fail to develop beyond the L1 stage. Briefly, each hermaphro-
dite mutant strain was crossed with male CB4856 and F1 progeny
were selected following single worm PCR with the following
Hawaiian genotyping primers (F1: GGGATCACCATATTTGGTAAGA,
R1: CATCGTGATGAAAAGTTGATGAC and F2: CGAGTAATGCTTCA-
GACAAGT). Multiple (>50) single F2 L4 progeny were then cul-
tured on 10 nM IVM plates and resistant populations were
selected after 5 days, then reselected for a further 5 days on a sec-
ond set of 10 nM IVM plates. The resistant Hawaiian crossed
nematodes from 50 individual overgrown plates were then
washed off, pooled and genomic DNA was prepared using a Gen-
tra Puregene Tissue kit (Qiagen, UK) and was cleaned and concen-
trated using a genomic DNA clean and concentrator kit (Zymo,
USA). The genomic DNA was sequenced via Illumina technology
on the MiSeq system using the MiSeq Reagent Kit v3 (600-
cycle). The sequence data was analysed using the CloudMap pipe-
line (Minevich et al., 2012) and the reads were aligned to the C.
elegans genome version WS220.64. Analyses were performed on
the Galaxy instance of Glasgow Polyomics, University of Glasgow,
UK (Giardine et al., 2005).2.5. Dil (1,10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanine
perchlorate) staining
All nematodes (C. elegans adults and H. contortus L2s) were
examined for amphidial Dil dye (Thermofisher, UK) uptake.
Nematode larvae were purified as in Section 2.1, washed in M9
buffer and incubated in 10 mg/ml of Dil for 3 h at room temperature
in the dark prior to washing with M9 and transferring to NGM
OP50-1 plates overnight. Nematodes were then picked to 2% agar-
ose pads for microscopy and imaging.2.6. RNA interference (RNAi) and IVM resistance selection
RNA interference (RNAi) clones (F18C12.1 and B0365.7) corre-
sponding, respectively, to the IVM resistance mapping candidates
TP238 che-3 (ka32) and TP239 dhc-3 (ka33), were recovered from
the C. elegans RNAi feeding library (Source Bioscience), streaked
on 100 lg/ml of ampicillin and 12.5 lg/ml of tetracycline Lauria
Broth and overnight cultures were subsequently prepared in Lauria
Broth medium with 100 lg/ml of ampicillin. N2 worms were
grown to the adult stage, then bleach treated to recover embryos
and 50 embryos were added to each 5 cm NGM plate. The RNAi
plates, che-3 (F18C12.1), dhc-3 (B0365.7) and empty vector
(L4440), all contained 100 lg/ml of ampicillin and 1 mM Isopropyl
b-D-1-thiogalactopyranoside (IPTG). Bacterial RNAi clones were
added and allowed to grow overnight, and N2 embryos were added
to RNAi plates and allowed to develop to adulthood for 3 days. Five
adults were then moved to a new RNAi plate (F18C12.1 to
F18C12.1, B0365.7 to B0365.7 and L4440 to L4440) supplemented
with 10 nM IVM and survival and development was assessed over
3 days.2.7. Imaging and microscopy
All nematodes were either viewed on plates using a Zeiss
benchtop microscope fitted with a Canon Sureshot camera or were
mounted on 2% agar pads on slides and viewed under Differential
Interference Contrast (DIC) or fluorescence optics on a Zeiss
Axioscop2 and imaged with a Zeiss AxioCam camera and
Axiovision software.3. Results
3.1. IVM resistance and Dil dye uptake
In this study, a robust IVM resistance assay was developed to
examine the correlation between low level (10–50 nM) macro-
cyclic lactone resistance and Dil dye exclusion from the sensory
amphids. When wild-type C. elegans embryos, L4s or adults were
placed on 10–50 nM IVM supplemented plates, no animals sur-
vived after 5 days (Fig. 1A). This is in contrast to confluent growth
noted on non-drug supplemented plates (with 1% DMSO) where F1
populations of wild-type embryos, active larvae and adults were
evident (Fig. 1B). Similar drug selection plates were then used to
isolate IVM- and abamectin-resistant mutants following chemical
mutagenesis (Fig. 1C) and to test pre-existing amphid defective
mutants that had not previously been assessed for IVM resistance
(Fig. 1D).
In addition to drug selection, the lipophilic dye Dil was applied
to examine the integrity of the amphid sensory structures in live
nematodes. In wild type C. elegans the fluorescent dye bound to
the amphid channels and the nerve ring structures in all larval
stages and adults (Fig. 1E), whereas this dye was excluded from
the majority of IVM-resistant (Fig. 1G; Table 1) and amphid defec-
tive mutants (Fig. 1H–J; Table 2). It is intriguing to note that this
dye also binds to the amphid structures and nerve ring of the L2
stage of the H. contortus IVM- and benzimidazole-sensitive strain
(MHco3 ISE) (Fig. 1L). Randomly picked L2s (39/39) displayed this
high level of dye filling following staining with Dil.
3.2. IVM resistance forward genetic screens
The four EMS mutagenesis IVM and abamectin resistance
screens generated 17 independent mutants that could survive nor-
mally lethal concentrations of IVM and abamectin (Table 1). These
mutants were all tested for Dil dye uptake, and 15 were found to
completely exclude Dil from the amphids and nerve ring
(Fig. 1G; Table 1). The two remaining strains, TP238(ka32) and
TP239(ka33) (Fig. 1F), displayed positive but variable Dil uptake,
independent of culturing on IVM or non-IVM selection plates.
Therefore 15/17 of the new macrocyclic lactone-resistant mutants
displayed impaired Dil uptake phenotypes with the remaining two
showing variable or near normal Dil uptake (Table 1). Resistance to
both macrocyclic lactones, abamectin and IVM, was found to be
linked to defective amphids in this nematode.
3.3. Hawaiian mapping and whole genome sequencing of IVM-
resistant, dyf-variable mutants
The two strains, TP238(ka32) and TP239(ka33), were selected
for whole genome sequencing as they displayed variable Dil uptake
and differed from the remaining 15, Dil excluding, macrocyclic lac-
tone resistance mutants. This analysis involved a Hawaiian, SNP-
rich strain (CB4856) backcrossing strategy, reselection for IVM
resistance, pooling of 50 individual backcrossed and resistant
strains, DNA purification and whole genome sequencing. This pow-
erful approach followed published methods (Doitsidou et al., 2010)
and allowed rapid mapping, resulting in the identification of a
novel che-3 allele (TP238, ka32) and a novel IVM resistance gene
dhc-3 (TP239, ka33). The whole genome sequencing and mapping
data is presented Supplementary Files S1 and S2. TP238(ka32)
encodes a C/T transition at position 8,070,133 on Chromosome I,
that results in a G/R change in codon 2568 of exon 30 of this dynein
heavy chain encoding gene. The mutation in dhc-3 of TP239(ka32),
also a dynein heavy chain encoding gene, was the result of a 104 bp
Fig. 1. Ivermectin resistance and amphid dye uptake in Caenorhabditis elegans. N2 wild type C. elegans after 5 days culture on 10 nM IVM, all nematodes are completely dead
(A), or 0 nM IVM (1% DMSO), healthy population (B). TP239(ka33), resistant population (C) and CB3330 che-11(e1810) after 5 days culture on 10 nM IVM, representing strong
resistance (D). A–D 40 magnification. Dil amphid dye uptake in wild type C. elegans N2 (E), and ivermectin-resistant mutant TP239(ka33) (F), and exclusion in ivermectin-
resistant mutant TP249(ka43) (G) and chemosensory mutant CB3330 che-11(e1810) (H), the osmotic avoidance mutant PR808 osm-1(p808) (I) and the dye-filling mutant
SP1735 dyf-7(m537) (J). Dil is also taken up by the amphids and binds the nerve ring of the L2 stage of Haemonchus contortus ivermectin- and benzimadazole-sensitive strain
(MHco3 ISE), differential interference contrast image (K), and U.V. image (L). Arrows depict amphids and arrow heads the nerve ring. E–L magnification 200.
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(13,150,172 to 13,150,276) which disrupts the final eight exons
of this very large transcript. Both of these mutations are predicted
to affect intraflagellar transport and are expected to be associated
with amphid structure in spite of the fact that Dil dye amphid
uptake was variable in these mutants.
The mapping candidates were examined further by obtaining
two of the available mutant alleles of che-3 and by applying an
RNAi approach to determine if knockdown of both candidate
genes would confer IVM resistance in the aforementioned IVM
plate assays (Fig. 2). Pre-existing mutants were only available
for che-3 but not dhc-3 (www.wormbase.org), and two indepen-
dent che-3 alleles (e1124 and e1253) were tested and found to
survive to adulthood on 10 nM IVM plates (Fig. 2C and D), being
comparable to the TP238(ka32) mutant strain (Fig. 2B) and in
marked contrast to the wild type strain N2, which arrests at L1
under identical selection conditions (Fig. 2A). The mapping data
was also supported for both che-3 and dhc-3 following and RNAi
approach whereby resistance to 10 nM IVM was conferred to the
normally susceptible N2 strain, by pre-exposing this strain to cor-
responding RNAi feeding constructs prior to exposure to 10 nM
IVM. The RNAi empty feeding vector control did not permit sur-
vival on 10 nM IVM (Fig. 2E) in contrast to the TP238(ka32)
(Fig. 2B) and TP239(ka33) (Fig. 2F) mutant strains which survived
this treatment. Similarly, the TP238(ka32) candidate che-3
(F18c12.1) (Fig. 2G) and the TP239(ka33) candidate dhc-3
(B0365.7) RNAi feeding (Fig. 2H) of the N2 strain both permitted
survival and allowed development to adulthood on the normally
lethal 10 nM IVM plates.3.4. IVM resistance screen based on pre-existing amphid defective
mutants
The strong link between amphid mutants and IVM resistance
was further investigated by examining the ability of previously
identified amphid mutants, that were not previously reported to
be resistant to IVM, to survive on 10 nM IVM plates (Table 2). A
subset of these mutants (che-1, che-11, che-13, osm-5, daf-10, dyf-
3, dyf-4, dyf-7, mec-8 and bbs-1) are described as having strong
resistance on 10 nM IVM plates, as they exhibited comparable
growth rates to those cultured on non-drug plates. An example
of a novel, strong IVM-resistant chemosensory defective strain
che-11(e1810) (Fig. 1D) and its ability to exclude Dil from the
amphids (Fig. 1H) is presented. This linkage of IVM resistance to
Dil exclusion is also shown for a representative osmotic avoidance
mutant osm-1(p808) (Fig. 1I), and a dye-filling mutant dyf-7(m537)
(Fig. 2J), both of which are resistant to IVM (Table 2). In total, 31
mutant strains from six different gene classes were tested and only
one, che-6(e1126), was found to be sensitive to 10 nM IVM. All 31
genes have been described as being dye-filling defective (Starich
et al., 1995), but only four (che-3, osm-1, osm-5 and dyf-11) had
previously been described as being resistant to IVM. Therefore, this
study has identified 26 new IVM resistance genes from C. elegans,
the majority of which are substitutions or nonsense mutations in
genes that encode proteins highlighted by homology to be involved
in intraflagellar transport within the amphids. In total, from these
investigations there are 20 genes that are listed as encoding pro-
teins involved in intraflagellar transport that when mutated result
in IVM resistance (Table 2).
Table 2
Many Caenorhabditis elegans amphid defective mutants are resistant to ivermectin and albendazole. Bold represents strong resistance (characterised as vigorous growth on 10 nM
ivermectin, comparable with non-drug plates and underlines represent previously identified dye-filling (Dyf) mutants that are resistant to ivermectin.
Gene (homology) Strain (allele) Mutation/effect IVM R ABZ R H. contortus homologue (% ID and aa length)
CHEmosensory mutants
che-1 (zinc finger Trans factor) PR672(p7672) Substitution/Nonsense Yes Yes No
che-2 (G-protein WD repeat) CB1033(e1033) Unknown Yes No Yes (56% over 281 aa)
che-3 (Dynein HC avr-1, IFT) CB1124(e1124) Substitution/Nonsense Yes No Yes (61% over 696 aa)
che-6 (cyclin channel) CB1126(e1126) Unknown No No Yes (58% over 238 aa)
che-10 (rootelin, IFT) CB3329(e1809) Unknown Yes No No
che-11 (large unfamiliar, IFT) CB3330(e1810) Substitution/Nonsense Yes Yes Yes (68% over 357 aa)
che-12 (creserin, IFT) CB3332(e1812) Splice site substitution Yes No Yes (56% over 236 aa)
che-13 (IFT57/Hippi) CB3323(e1815) Substitution/Nonsense Yes Yes Yes (53% over 209 aa)
che-14 (sterol sensing) CB3687(e1960) Splice site substitution Yes No Yes (59% over 391 aa)
OSMotic avoidance mutants
osm-1 (WD repeat IFT) PR808(p808) Unknown Yes No Yes (55% over 714 aa)
osm-3 (kinesin family IFT) PR802(p802) Substitution/Nonsense Yes No Yes (87% over 328 aa)
osm-5 (polaris IFT) PR813(p813) Substitution/Nonsense Yes Yes
a Yes (69% over 391 aa)
osm-6 (novel IFT) PR811(p811) Splice site substitution Yes No Yes (52% over 233 aa)
osm-12 (bbs7 IFT) MT3645(n1606) Substitution/Nonsense Yes No Yes (59% over 270 aa)
DAuer DeFectice mutants
daf-10 (WD repeat IFT) CB1387(e1387 Substitution/Nonsense Yes Yesa Yes (60% over 313 aa)
daf-19 (RFX transfer factor) DR86(m86) Substitution/Nonsense Yes No Yes (69% over 186 aa)
DYeFilling defective mutants
dyf-1 (novel IFT) SP1205(mn335) Insertion/ frameshift Yes No Yes (60% over 353 aa)
dyf-2 (WRD19 IFT) SP1234(m160) Substitution/Nonsense Yes No Yes (58% over 250 aa)
dyf-3 (CLUAP protein IFT) SP1603(m185) Substitution/Nonsense Yes Yes Yes (58% over 231 aa)
dyf-4 (uncloned) SP1237(m158) Unknown Yes Yesa uncloned
dyf-5 (map kinase) SP1745(mn400) Substitution/Nonsense Yes No Yes (85% over 315 aa)
dyf-6 (novel IFT) SP1712(m175) Substitution/Nonsense Yes No No
dyf-7 (ZP protein) SP1735(m537) Unknown Yes Yesa Yes (66% over 132 aa)
dyf-9 (uncloned) MT3559(n1513) Unknown Yes No uncloned
dyf-10 (uncloned) SP1709(e1383) Unknown Yes No uncloned
dyf-11 (IFT54 homolog IFT) SP1713(mn392) Substitution/Nonsense Yes No No
dyf-13 (novel IFT) SP1678(mn396) Splice site substitution Yes No Yes (46% over 291 aa)
MEChanosensory defective
mec-1 (EGF/Kunitz) CB1066(e1066) Splice site substitution Yes No Yes (57% over 227 aa)
mec-8 (RRM domain) CB398(e398) Substitution/Nonsense Yes Yes Yes (85% over 95 aa)
Bardet-Biedl syndrome protein
bbs-1 (BBS1 ortholog IFT) VC837(ok1111) Deletion coding Yes Yesa Yes (41% over 168 aa)
bbs-8 (TPR protein IFT) MX52(nx77) Deletion coding Yes No Yes (58% over 356 aa)
Novel EMS derived IVM resistance gene
dhc-3 (Dynein, IFT) TP239 Insertion/frameshift Yes No No
IVM R, 10 nM ivermectin-resistant; ABZ R, 100 mM albendazole resistant, (a, represents ABZ resistance to 150 mM); IFT, intraflagellar transport component homology.
Haemonchus contortus homologues were investigated by BLASTP using Wormbaseparasite (WBPS10, WS236) with hits shown as % identity over a specified amino acid (aa)
length.
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ularly defined mutants are found in the almost completely
sequenced genome of the parasitic nematode H. contortus (Table 2).
This analysis was done by BLASTP analysis of the C. elegans homo-
logues against the Wormbase parasite database (WBPS 10). The
absence of che-1, che-10, dyf-6, dyf-11 and dhc-3 may reflect the
fact that the currently available genomes of H. contortus are incom-
plete (Laing et al., 2013; Schwarz et al., 2013). These homologues
include 7/9 chemosensory mutants, 5/5 osmotic avoidance
mutants, 2/2 dauer defective mutants, 6/8 dye-filling mutants,
2/2 mechanosensory mutants and 2/2 Bardet-Biedl syndrome
mutants (Table 2).
3.5. ABZ resistance screen
In the field of veterinary parasitology there are many examples
of common trichostrongylid parasites, closely related to C. elegans,that are resistant to combinations of different classes of anthel-
minthic drugs including the macrocyclic lactones and the benzim-
idazoles (Sargison et al., 2007). To address multi-drug resistance in
the amphid mutants of C. elegans, nematodes were cultured on
plates supplemented with 100 mM ABZ and populations were
assessed for paralysis (immotile) and death after 3–5 days of expo-
sure. Nematodes from the mutagenesis screen (Table 1) and the
defective amphid mutant collection, (Table 2) were assessed for
resistance to ABZ. From the forward genetic screen only one strain,
TP241(ka35), was resistant to both the macrocyclic lactones and
the benzimidazole drug ABZ (Table 1). From the amphid mutant
collection, 10 of the 31 mutants were also found to be resistant
to 100 mM ABZ (Table 2), with at least one member of each gene
class having this multiple resistance, and five of these (che-11,
osm-5, daf-10, dyf-3 and bbs-1) also being predicted by homology
to play roles in intraflagellar transport. Five of the amphid-
related mutants (osm-5, daf-10, dyf-4, dyf-7 and bbs-1) exhibited
Fig. 2. Confirmation of ivermectin resistance genes identified by whole genome sequencing by testing on 10 nM ivermectin plates. Wild type N2 were killed and failed to
progress beyond L1 (A), compared with TP238 which survive to adult stage on 10 nM IVM (B). TP238(ka32) mapping candidate alleles CB1124(che-3, e1124) (C) CB1253 (che-
3, e1253) (D) also survive to adult stage on 10 nM IVM plates. A–D, 20 embryos added per plate and left or 3 days, (magnification 80). RNA interference (RNAi) testing of
candidate genes for resistance to 10 nM ivermectin. E–H (40). Empty vector RNAi control (L4440) treated N2 killed on 10 nM ivermectin (E) compared with resistant strain
TP239(ka33) (F) which progresses to adulthood. TP238(ka32) mapping candidate che-3 (F18C12.1 RNAi) fed to N2 strain (G) and TP239(ka33) mapping candidate dhc-3
(B0365.7 RNAi) fed to N2 strain (H); both survived to adulthood on 10 nM ivermectin.
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150 mM ABZ plates. These five mutants were also denoted as hav-
ing strong resistance to IVM (Table 2). Of the 10 shared IVM- and
ABZ-resistant mutants, nine have been molecularly defined and
eight of these genes have homologues present in the H. contortus
genome, five of the eight being predicted to be associated with
intraflagellar transport (Table 2).4. Discussion
This study clearly indicates that the amphids represent the
main route of IVM uptake into C. elegans, and that mutation of
genes that cause amphid defects, predominantly in the intraflagel-
lar transport machinery, are the primary mode of IVM resistance in
this nematode species. This genetic study strongly supports this
hypothesis as four random forward genetic screens, comprising
>400,000 mutagenised genomes, generated amphid defects associ-
ated with resistance to the macrocyclic lactones. All the drug-
resistant mutants from these screens had defects related to the
amphids. These mutants were selected for resistance on 10 nM
and 50 nM IVM and 50 nM abamectin, a concentration that is com-
parable to the clinical bloodstream concentration required to kill
ruminant nematodes in the host (Alvinerie et al., 2008). In total,
17 independent drug resistance alleles were isolated and then
tested in a dye uptake assay. Fifteen mutants completely excluded
the dye, indicating a clear defect in their amphids. The remaining
two mutants, which showed a near wild-type phenotype of dye
uptake, were analysed by SNP-based mapping and whole genome
sequencing methods (Doitsidou et al., 2010). This study uncovered
mutations in amphid-associated intraflagellar transport genes pre-
sent within the mapped regions, namely a novel allele of the gene
che-3, also known as avermectin resistant gene 1 (avr-1), a dynein-
heavy chain encoding gene that was isolated in previous aver-
mectin resistance screens (Dent et al., 2000). In addition, a novel
IVM resistance associated dynein motor protein component (dhc-
3, B0365.7), that is a paralogue of che-3, was identified in this cur-
rent screen. This suggests that, although able to take up dyes, theamphids in these two mutants are also likely to be structurally
defective or unable to transport the drug effectively. The identity
of these mutants has been further confirmed by examining the
ability of additional mutant alleles of che-3 and RNAi knockdown
of both che-3 and dhc-3 to survive normally lethal concentrations
of IVM.
In these unbiased, random genetic screens the 100% (17/17)
correlation with amphid defects is remarkable, supporting the
hypothesis that defective amphid function causes resistance to
clinically relevant concentrations of IVM in this nematode species.
It is highly likely that the remaining unmapped and unsequenced
mutants will also encode previously identified targets in the
amphid structural and intraflagellar transport machinery path-
ways. It is interesting to note that che-3 is a very large gene,
(25.5 kb coding sequence) and therefore likely to be targeted sev-
eral times during an EMS screen. Indeed, 21 mutant alleles of
che-3 were isolated during a separate unrelated genetic screen
for Dyf mutants (Starich et al., 1995). CHE-3 has been shown to
be expressed in the amphids, be involved in intraflagellar transport
and through mutant analysis has been shown to be involved in
maintaining the structural integrity of the ciliated sensory ending
in C. elegans (Wicks et al., 2000). DHC-3 is a less well characterised
intraflagellar transport component but has been shown to be
expressed in the sensory amphids and is predicted to be involved
in transport in a defined subset of the amphidial neurones (OLQ)
(Hao et al., 2011). Sensory cilia are assembled by intraflagellar
transport via anterograde movement of intraflagellar transport
particles, whereas retrograde transport is responsible for recycling
the transport components back to the base of the cilium and is
mediated by the large multi-subunit complexes called dyneins.
This transport process and its key components have been eluci-
dated in C. elegans and are reviewed in detail elsewhere (Inglis
et al., 2007).
To further test the striking association between amphid defects
and IVM resistance, available C. elegansmutants that had been pre-
viously selected based solely on their amphid-defective pheno-
types such as Osm, Daf, Che (Starich et al., 1995), and not by
resistance to IVM, were also tested for anthelmintic resistance.
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the Che, Osm, Dyf, Daf, mechanosensation (Mec) and Bardet-Biedl
syndrome (Bbs) gene classes were tested for survival on normally
lethal 10 nM IVM plates. Mutants of the four genes osm-1, osm-5,
dyf-11 and che-3 identified previously as causing IVM resistance
(Dent et al., 2000) were included as positive controls. Strains tested
were found (30/31) to be resistant to IVM (Table 2). Based solely on
the defective amphid phenotype, 26 novel IVM resistance genes
have now been identified, unequivocally demonstrating the impor-
tance of amphid function for IVM resistance in C. elegans. The 26
novel resistance strains include molecularly defined loci, 19 of
which are intriguingly listed as genes involved in ciliogenesis and
intraflagellar transport (Inglis et al., 2007). Where possible, the ref-
erence alleles were selected for testing, with multiple additional
amphid mutant alleles being listed as available but so far untested
with respect to IVM resistance (www.wormbase.org). Of the alleles
tested, the molecular nature of 23 are known, and 15 are nonsense
mutations and are therefore predicted to be null alleles; an addi-
tional two were splice site mutants and three contained either
deletions or insertions with the remaining seven currently listed
as uncloned. Intriguingly, 13/30 of the IVM-resistant amphid
mutants were also established as being resistant to high concentra-
tions (100–150 mM) of ABZ, a chemically unrelated benzimidazole
anthelmintic (Table 1). There are well established mechanisms of
nematode resistance to benzimidazoles linking mutations in the
drug target, b-tubulin (Kwa et al., 1994); however recent analysis
has also identified a wide range of natural mutations in Caenorhab-
ditis spp. that are distinct from these known target resistance genes
(Zamanian et al., 2018). This observation raises the possibility that
common or closely related uptake or transport mechanisms may
also be responsible for resistance to diverse anthelmintic
compounds and may help to explain certain aspects of the multi-
drug resistance observed in field isolates of nematodes of
veterinary importance. Indeed, a common theme noted in this
cross-resistance was that genes with functional roles in amphid
ciliogenesis and intraflagellar transport predominated (eg, che-13,
osm-5, and bbs-1; see Table 2).
It can therefore be concluded that the anterior amphidial sen-
sory organs represent a major route of macrocyclic lactone drug
uptake and that mutations in this uptake and transport mechanism
represent the primary source of drug resistance in this model
nematode, and by inference may be involved in the widespread
resistance now noted in the parasitic nematodes. In support of this,
a correlation has previously been made between the length and
organisation of the amphid sensilla and IVM tolerance/resistance
in both C. elegans (Dent et al., 2000) and the parasitic nematode
H. contortus (Freeman et al., 2003). Thus shortening, regeneration
and/or loss of structural integrity of amphids in nematodes are
thought to reduce their ability to transport compounds. Similarly,
uptake and toxicity of low levels of aldicarb are associated with
the amphids of plant parasitic nematodes (Winter et al., 2002). Pre-
vious electron microscopic analysis of H. contortus revealed shorter
amphid cilia in IVM-resistant strains than in IVM-sensitive nema-
todes, giving a strong indication that the amphids do indeed play a
role in both IVM entry and drug sensitivity (Freeman et al., 2003). A
recent study also indicated the importance of the dyf-7 gene,
required for amphid cilia formation, in IVM resistance in C. elegans
and in several H. contortus IVM-resistant strains (Urdaneta-
Marquez et al., 2014). These authors also found a link between
dye exclusion and IVM resistance in strains of H. contortus
(Urdaneta-Marquez et al., 2014). A link between the amphids
and drug resistance in C. elegans was further established recently
when long-term exposure to the macrocyclic lactone moxidectin
was also found to result in amphid defects (Menez et al., 2016).
Other than these reports, the role of the amphids in drug resistance
in parasitic nematodes remains a relatively unexplored, butpotentially profitable, avenue of future research. It is significant
to note that in this study, the lipophilic dye Dil was able to enter
and stain the amphidial and nerve ring structures of a known
macrocyclic lactone and benzimidazole-sensitive strain of H. con-
tortus (MHco3 ISE) (Fig. 1L). It is also significant to note that the
majority (83%) of the novel IVM resistance genes identified in this
study have a homologue in this important parasite species
(Table 1).
The fact that numerous individual amphid associated genes can
be mutated to give resistance indicates a large degree of redun-
dancy and may explain why the identification and confirmation
of a single gene mutant associated with IVM resistance in the tri-
chostrongylid nematode parasites has, to date, remained elusive.
Critical questions arising from these studies are: (i) how wide-
spread are the amphid defects in IVM-resistant field and laboratory
isolates of key parasitic nematodes and (ii) how does this uptake
mechanism relate to macrocyclic lactone, benzimidazole, levami-
sole and multi-drug resistance? (iii) What are the consequences
of amphid gene mutation on parasite nematodes in the field;
would they confer a developmental advantage or disadvantage?
(iv) Can this uptake route and mode of transport be exploited in
future drug development strategies and finally, (v) can the amphid
defective phenotype be utilised as a potential marker of selective
or indeed multi-drug resistance in the field?
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